Products

Duhuo Jisheng Powder Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    • Product Name: Duhuo Jisheng Powder Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications
    HS Code 288230
    Product Name Duhuo Jisheng Powder Veterinary Grade API
    Api Source Duhuo (Angelica pubescens) and Jisheng (Taxillus chinensis) based traditional Chinese medicine extraction
    Active Principles Osthole, aucubin, loganin, and other bioavailable phytochemical markers
    Veterinary Target Species Cattle, swine, sheep, goats, horses, dogs, cats, and poultry
    Therapeutic Indications For adjunctive management of arthralgia, lumbar pain, weakness in knees, and bi-syndrome associated with wind-cold-damp invasion
    Available Dosage Forms Tablets, injections, capsules, powders, granules, premix, and oral solutions
    Physicochemical Form Fine, free-flowing powder with characteristic herbal odor and slightly bitter taste
    Solubility Profile Soluble in hydroalcoholic systems; forms homogeneous suspension in aqueous vehicles for liquid formulations
    Pharmacological Action Anti-inflammatory, analgesic, antioxidant, and immunomodulatory activities supporting musculoskeletal health
    Quality Specification Veterinary grade API compliant with internal monograph standards for assay, loss on drying, heavy metals, and microbial limits
    Storage Conditions Store in well-closed containers, protected from light, moisture, and temperatures below 25°C
    Shelf Life 24 months from date of manufacture if stored unopened under recommended conditions
    Safety Status Low toxicity profile; withdrawal period as established by local veterinary regulatory authority
    Compatibility Compatible with common excipients used in solid, liquid, and parenteral veterinary preparations
    Regulatory Compliance Manufactured in accordance with GMP and veterinary pharmacopeial standards for veterinary active pharmaceutical ingredients

    As an accredited Duhuo Jisheng Powder Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Packaged in sealed double-layer polyethylene bags inside fiber drums, 25 kg net per drum, ensuring stability and safety for veterinary pharmaceutical manufacturing.
    Container Loading (20′ FCL) 20′ FCL container loaded with palletized, sealed drums of Duhuo Jisheng Powder veterinary API, safely secured for transit.
    Shipping Shipments of Duhuo Jisheng Powder Veterinary Grade API are packaged in sealed, moisture-proof containers to maintain stability. For powders, granules, premixes, and solutions, protective secondary packaging prevents leakage. Products are transported at controlled ambient temperature, away from direct sunlight. Documentation includes Safety Data Sheet and certificate of analysis for regulatory compliance.
    Storage Store in a tightly sealed, original container in a cool, dry, well-ventilated area away from direct sunlight, heat, and moisture. Keep protected from extreme temperatures and incompatible substances. Ensure container is securely closed after each use. Store out of reach of children and animals. Use within designated shelf life.
    Shelf Life Shelf life: 24 months when stored unopened in a cool, dry, well-ventilated area, protected from light and moisture.
    Application of Duhuo Jisheng Powder Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    Direct compression of Duhuo Jisheng Powder begins with size classification on a vibratory sieve fitted with a 60-mesh (250 µm) screen. The coarse fraction contains lignified stem fragments from the multi-herb matrix and is re-milled through a pin mill at a rotor speed of 7,000 rpm. Batch records from rotary tablet presses with 10-mm round flat-faced tooling show that unlubricated compression of neat botanical powder causes sticking on punch faces at hardness above 70 N. The working blend is therefore prepared in a 600-L V-blender in the following order: Duhuo Jisheng Powder 25.0–35.0% w/w, silicified microcrystalline cellulose 35.0–45.0% w/w, mannitol 10.0–20.0% w/w, croscarmellose sodium 3.0% w/w, and magnesium stearate 0.5–1.0% w/w added after 15 min of preblending. Compression force is held at 8–12 kN to yield tablets with hardness 60–90 N and friability below 1.0% by Ph. Eur. 2.9.7. Aqueous film coating with hydroxypropyl methylcellulose 6 cps grade reduces moisture ingress and masks the aromatic coumarin layer; coating pan inlet air temperature is set at 60–65°C. The finished film-coated tablets are intended for canine and equine musculoskeletal support, with batch release requiring osthole and geniposide assay by HPLC using the active marker content stated on the API certificate.

    What Limits Terminal Sterilization of Injectable Solutions Containing Multi-Herb Extracts?

    Aqueous extraction of Duhuo Jisheng Powder for parenteral use is initiated with a powder-to-Water-for-Injection ratio of 1:10 w/v at 60°C for 30 min. The decoction is vacuum-filtered through a 0.45 µm polyethersulfone membrane to remove pectic polysaccharides and lignified fiber; this step is repeated before final sterile filtration. Tannin-coumarin complexes precipitate when the extract is cooled below 20°C, so the holding temperature between processing steps is maintained at 25–30°C. pH is adjusted with disodium hydrogen phosphate to 5.5–6.5, because alkaline pH accelerates hydrolysis of the ester-linked coumarins and acidic pH destabilizes the isoflavone fraction. Terminal steam sterilization at 121°C for 15 min is limited by degradation of marker compounds; therefore, aseptic filtration through a 0.22 µm membrane in an ISO 14644-1 class 7 cleanroom is used for heat-labile batches. Multi-dose vials require 2.0% benzyl alcohol as a preservative and are filled into 20 mL amber borosilicate Type I glass. Sterility testing follows Ph. Eur. 2.6.1, and pyrogenicity testing follows Ph. Eur. 2.6.8. Finished injectable solutions are compounded for equine intramuscular or bovine subcutaneous veterinary use, not for direct injection of the raw powder. Published stability data specific to this multi-herb injection are limited; therefore, each batch is bracketed by marker recovery after 3, 6, and 12 months at 25°C/60% RH.

    When Duhuo Jisheng Powder Is Incorporated into Pelleted Premixes for Swine and Poultry

    In pelleted feed manufacturing, direct addition of undiluted botanical powder to a horizontal ribbon mixer at 1–3% w/w of complete feed is possible only after preblending with calcium carbonate or wheat middling carrier at a 1:9 ratio to prevent electrostatic segregation. The preblend is transferred to a counterflow cooler after pellet pressing at conditioning temperatures of 75–85°C for 20–40 s. Because coumarin marker content declines when the moist meal is exposed to steam conditioning above 80°C, post-pelleting liquid application through a 0.5 mm nozzle onto cooled pellets is preferred for heat-sensitive batches. Pellet durability index is maintained above 95% by the addition of 0.5–1.0% sodium bentonite, which also controls dust generation during bagging. The finished premix is commonly packaged in 25 kg valve bags with a moisture barrier liner; loss on drying is controlled below 8.0%. Heavy metal limits follow Ph. Eur. 2.4.8, and aflatoxin B1 is monitored by HPLC with a limit of quantification below 0.5 µg/kg in the final feed. Terminal pelleted premixes are supplied for grower swine and layer poultry rations, with the active botanical fraction adjusted based on the osthole assay of the API lot. Published data for residual coumarin retention under long-duration pelleted feed storage is limited, so batch-specific retention samples are retained for 24 months.

    Fluid-bed granulation of Duhuo Jisheng Powder avoids the extruder torque spikes observed with high-fiber botanical matrices on twin-screw wet granulators with L/D ratios above 20:1. A top-spray fluid-bed granulator with a 2.0 mm nozzle is charged with the botanical powder and lactose monohydrate at a 1:1 ratio. The binder solution is 5.0% w/w povidone K30 in ethanol-water 30:70 v/v, sprayed at 8–12 g/min. Inlet air temperature is controlled at 60–70°C, product temperature at 32–38°C, and air flow at 60–100 m³/h; these settings maintain granule moisture below 5.0%. Dried granules are passed through a 16-mesh (1.18 mm) sieve, and fines below 30 mesh (595 µm) are recycled to the next granulation batch. The finished granules are filled into 10 g sachets containing 20–40% w/w active botanical fraction, with sorbitol and silica as flow modifiers. This oral granule presentation is intended for in-feed administration to equine or bovine animals where tablet administration is not practical. For dry oral powders, the milled API is blended with dextrose monohydrate in a 1:4 ratio and passed through a 40-mesh (425 µm) screen; the powder is packed into foil-lined sachets. Batch release includes bulk density 0.45–0.65 g/mL by USP <616> and loss on drying below 5.0%. The terminal sachet product requires storage below 25°C and below 60% RH to prevent hygroscopic caking.

    Veterinary Drinking-Water Soluble Powder Dispersions and In-Line Filtration Limits

    Micronized Duhuo Jisheng Powder disperses in hard water only as a suspension; true aqueous solubility of the coumarin-rich fraction is below 1.0 g/L. To prepare a drinking-water suspension concentrate, the powder is first air-jet milled to D90 < 50 µm and then mixed with polysorbate 80 at 0.5–2.0%, xanthan gum at 0.1–0.3%, and citric acid to pH 4.0–5.0. The concentrate is diluted in a medicator at 1:50 to 1:200 parts of drinking water. In-line distribution lines should be fitted with 200 µm screen filters; filters of 100 µm or less clog within 30 min under high-fiber batch conditions. Continuous recirculation is required because sedimentation begins after 4 h without agitation. Terminal solutions are administered to broiler and weaning piglet flocks for short-course musculoskeletal support during high-stocking-density periods. Each drinking-water batch is inspected for sedimentation ratio and pH; microbiological quality follows the farm water quality plan. The primary stability limitation is microbial growth in medicated water, so the suspension is used within 24 h after preparation. Published data for oral bioavailability from drinking-water administration of this specific multi-herb suspension is limited.

    Capsule Filling Requires Particle Size Reduction Below 180 µm Prior to Tamping

    Low-density botanical powders with high fiber content exhibit poor flow into capsule bodies; Duhuo Jisheng Powder is therefore impact-milled to D90 < 180 µm and blended with lactose monohydrate at a 1:1 ratio. The blend is dried to a loss-on-drying value below 6.0% before loading into a semi-automatic capsule filler with tamping pin penetration set at 10–12 mm. Size 1 hard gelatin capsules are filled to a target weight of 400 mg ± 5%; capsule fill weight variation is checked according to USP <905>. Gelatin shell brittleness is minimized by maintaining the filling room at 40–50% RH and 20–22°C. The filled capsules are dusted and polished on a rotating brush machine, then packed into 60-mL high-density polyethylene bottles with desiccant. This capsule presentation is intended for companion animal veterinary use where weight-based dosing permits more precise administration than feed premixes. Batch release requires coumarin marker assay by HPLC and microbial limits according to Ph. Eur. 5.1.4. Storage is specified below 25°C; moisture ingress above 60% RH darkens the gelatin shell and accelerates cross-linking of the powder matrix.

    Free Quote

    Competitive Duhuo Jisheng Powder Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Inquiry

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Designated in supplier traceability records as Duhuo Jisheng Powder Veterinary Grade API, the material is a multi-herb native extract powder prepared from a decoction containing Angelica pubescens var. biserrata radix, Taxillus chinensis herba, Angelica sinensis radix, Saposhnikovia divaricata radix, Asarum heterotropoides radix et rhizoma, Cinnamomum cassia ramulus, Achyranthes bidentata radix, Paeonia lactiflora radix, and other formula constituents. The dried extract is milled and classified for downstream conversion into tablets, hard capsules, granules, oral powders, premixes, and—after further purification or sterile filtration—solutions and injectable preparations. Extract ratio is supplier-defined and is commonly stated as 5:1 or 10:1 relative to crude herb weight; model codes are not harmonised across the veterinary API supply chain and typically encode extract ratio, mesh class, and dosage-form compatibility. Identification is performed by thin-layer chromatography against certified botanical reference materials, with quantification of major marker compounds such as osthole, columbianadin, and ligustilide by HPLC-DAD. Published method validation data for the complete multi-herb matrix remain limited, and batch-to-batch marker variability is managed through extract ratio control and blending of sub-lots.

    What Release Attributes Separate Injection-Grade Lots from Tablet- and Premix-Grade Material?

    Veterinary-grade Duhuo Jisheng Powder is not a single fixed specification; release criteria are aligned to the final dosage form. For dry oral solid dosage forms, particle size is routinely controlled to a D90 of ≤250 µm by laser diffraction per ISO 13320:2020, and loss on drying is held at ≤5.0% when tested by vacuum oven at 70 °C to constant weight. Injection-grade material, in contrast, is pre-filtered through depth filtration and a final 0.22 µm polyethersulfone filter before lyophilisation or sterile filling; insoluble particulate matter counts are then assessed per USP <786> / Ph. Eur. 2.9.19, and bacterial endotoxins are controlled to ≤0.5 EU/mg by gel-clot Ph. Eur. 2.6.14. Bioburden for non-sterile oral grades is typically ≤10³ CFU/g with absence of Escherichia coli and Salmonella per ISO 11737-1:2018. Heavy metal limits for lead, cadmium, arsenic, and mercury are determined by ICP-MS per ISO 17294-2:2016 after microwave-assisted digestion. Residual solvent levels are reviewed against VICH GL18; ethanol and methanol are the primary solvents declared in wet granulation or extraction steps.

    Representative release specification matrix for Duhuo Jisheng Powder Veterinary Grade API by intended dosage form
    Parameter Tablet / Capsule / Premix Grade Injection / Sterile Solution Grade Test Method Designation
    Appearance Brown to yellow-brown amorphous powder Clarified aqueous concentrate or lyophilised powder Visual inspection under D65 light
    Particle size D90 ≤250 µm for direct compression; ≤180 µm for low-dose premix Particulate matter controlled after 0.22 µm filtration ISO 13320:2020; USP <786>
    Loss on drying ≤5.0% ≤3.0% after lyophilisation Vacuum oven at 70 °C
    Total ash ≤6.0% ≤4.0% Residue on ignition method
    Heavy metals Pb / Cd / As / Hg Each ≤5 ppm Each ≤2 ppm ISO 17294-2:2016 after microwave digestion
    Bioburden ≤10³ CFU/g; no E. coli or Salmonella Sterile per Ph. Eur. 5.1.1 ISO 11737-1:2018
    Bacterial endotoxins Not specified for non-sterile oral routes ≤0.5 EU/mg Ph. Eur. 2.6.14
    Marker content sum Osthole and columbianadin ≥0.5% Osthole and columbianadin ≥0.6% HPLC-DAD with certified references
    Residual solvents Complies with VICH GL18 declared limits Complies with VICH GL18 declared limits Headspace GC-FID

    During direct compression campaigns on rotary tablet presses fitted with precompression stations, the powder’s bulk density is typically adjusted to 0.45–0.65 g/mL and tapped density to 0.55–0.80 g/mL; compressibility at 10 kN precompression force is evaluated through tablet hardness and disintegration rather than isolated Heckel parameters because the multi-component extract exhibits viscoelastic deformation. Blend uniformity is tested according to USP <905> with acceptance value ≤15.0 for compacted dosage units. For wet granulation, a high-shear granulator with impeller speed 150–250 rpm and chopper speed 1000–1500 rpm is used, followed by fluid-bed drying at inlet air temperature 50–60 °C until moisture is ≤3.0%. Addition of microcrystalline cellulose at 10–25 wt% and croscarmellose sodium at 2–5 wt% is typical in development trials, but formulation-specific compatibility must be confirmed against the full botanical matrix.

    When Low-Dose Premix Blending Approaches the Limit of Segregation

    In premix applications where the API is added at 0.5–2.0 kg/tonne, segregation and electrostatic adhesion become governing variables. Pilot-scale ribbon blenders with working volume 200–500 L and fill level 60–70% produce acceptable homogeneity when the API is pre-blended with calcium carbonate or lactose monohydrate carrier at 1:9 before addition to the main feed. Blend uniformity is challenged by particle size mismatch: carrier D50 100–200 µm versus API D50 25–45 µm can create fines-rich regions unless the API is agglomerated or granulated onto the carrier. Electrostatic charging is controlled by maintaining processing area humidity at 45–55% RH; above 60% RH, hygroscopic fractions in the extract may form clumps that fail to pass a 500 µm sieve after 10 minutes of vibration per ISO 2591-1:2008. Equipment observations from manufacturing campaigns show that direct addition of non-granulated extract to a low-shear tumbler without carrier pre-blending can produce relative standard deviation values above 6.0% in first-pass powder sampling, necessitating extended blending or geometric dilution.

    Stability Boundaries Under Humid and Thermal Stress

    Accelerated stability data for veterinary herbal extract powders generally indicate moisture- and temperature-dependent degradation of osthole and coumarin-type markers. Storage of bulk API in double polyethylene-lined fibre drums at 25±2 °C and ≤60% RH retains marker content within ±10% of initial over 24 months when desiccant is included and headspace is nitrogen-flushed. At 40 °C and 75% RH, unprotected samples show measurable softening and caking within 7 days, with loss on drying rising above 7.0%; opened drums should be re-sealed under dry nitrogen and used within 30 days. The API is incompatible with strong oxidising acids, strong alkalis, and concentrated peroxide disinfectants; co-storage with volatile amines is not recommended because amine vapours can accelerate browning. For aqueous solution preparation, the extract is dissolved or dispersed at 40–50 °C in purified water, then cooled and filtered; prolonged exposure above 60 °C for more than 2 hours may reduce marker recovery by hydrolysis of ligustilide. Published data for this specific configuration is limited for long-term sterile solution stability, so each formulation should be bracketed using VICH GL3 stability protocols.

    The Extract Differs from Isolated NSAID APIs in Marker Complexity and in Traditional Formula Intent

    At the formulation level, Duhuo Jisheng Powder is a multi-constituent extract rather than a single synthetic molecule; therefore no single IC50 value for cyclooxygenase inhibition or a defined pharmacokinetic half-life can be assigned. In contrast, flunixin meglumine and meloxicam are single active moieties with published target-binding and residue depletion data in cattle and horses. The extract’s batch-to-batch composition is controlled through chromatographic fingerprinting and marker content, but pharmacological equivalence to isolated NSAIDs is not demonstrated by published veterinary clinical trials. Among traditional wind-damp formulas, Duhuo Jisheng San differs from Qianghuo Shengshi San in that it includes Taxillus chinensis herba and Achyranthes bidentata radix, ingredients traditionally classified as liver- and kidney-tonifying, and is therefore used in chronic bi syndrome with deficiency rather than acute wind-cold-damp invasion. This distinction is a materia medica formulation difference; it does not imply a quantifiable mechanism of action in a specific species.

    Gross formulation and manufacturing distinctions between Duhuo Jisheng Powder, an adjacent wind-damp formula, and an isolated NSAID API
    Distribution attribute Duhuo Jisheng Powder Veterinary Grade API Qianghuo Shengshi San-type extract Isolated NSAID, flunixin meglumine
    Composition class Multi-herb extract with coumarins, phenylpropanoids, and terpenoids Multi-herb extract with coumarins and monoterpenoids Single synthetic molecule
    Marker control Osthole, columbianadin, ligustilide by HPLC-DAD Imperatorin, notopterol by HPLC-DAD Single assay for active moiety
    Primary manufacturing route Dry blending, wet granulation, sterile filtration for injectables Dry blending, oral solutions Aqueous injection, oral granulation
    Critical release limit Endotoxin ≤0.5 EU/mg for injection grade; bioburden ≤10³ CFU/g for oral grade Bioburden ≤10³ CFU/g for oral grade Impurity profile per pharmacopoeial monograph
    Residue depletion data Limited published data for target species Limited published data for target species Established withdrawal times in cattle and horses

    Bulk supply of non-sterile Duhuo Jisheng Powder is normally packaged in 20 kg or 25 kg HDPE drums with double LDPE liners, desiccant sachet, and tamper-evident closure. Sterile injection-grade lyophilisate is supplied in borosilicate glass vials sealed under vacuum or nitrogen. Because the powder is hygroscopic, containers should not be opened in production areas exceeding 60% RH, and any portion removed should not be returned to the original drum. For cross-contamination control, dedicated scoops and transfer lines are used; wet cleaning with strong oxidising agents is avoided because surface residues may bind to the extract and create extractable artifacts. Since published data for this specific configuration is limited for several parenteral formulation routes, pilot-scale filtration trials using 0.45 µm followed by 0.22 µm PES membranes are recommended to characterise throughput and marker recovery before full-scale sterile manufacturing.

    Top